After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the AMEX and operates within the Medical Devices industry segment. The current market capitalization of Zomedica Corp is $137.19M. A total of 7.16 million shares were traded on the day, compared to an average of 5.60M shares.
In the most recent transaction, POWERS JOHNNY D bought 100,000 shares of ZOM for 0.17 per share on Dec 15 ’23. After the transaction, the Director now owns 1,950 company shares. In a previous transaction on Nov 17 ’23, POWERS JOHNNY D bought 100,000 shares at 0.17 per share. ZOM shares that Director owns now total 1,850,000.
Among the insiders who bought shares, HEATON LARRY C II acquired of 100,000 shares on Nov 17 ’23 at a per-share price of $0.17. This resulted in the CEO holding 200,000 shares of ZOM after the transaction. In another insider transaction, POWERS JOHNNY D bought 150,000 shares at $0.17 per share on Nov 15 ’23. Company shares held by the Director now total 1,750,000.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, ZOM has a high of $0.25 and a low of $0.12.
As of this writing, ZOM has an earnings estimate of $0 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $0 per share and a lower estimate of $0.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ZOM’s latest balance sheet shows that the firm has $194.95M in Cash & Short Term Investments as of fiscal 2021. There were $1.38M in debt and $4.34M in liabilities at the time. Its Book Value Per Share was $0.24, while its Total Shareholder’s Equity was $270.89M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ZOM is Buy with a score of 3.00.
